… Conflict of Interest Disclosures: Dr Amezcua reports personal compensation for consulting,
speaking, or serving on steering committees or advisory boards for Alexion Pharmaceuticals, …

Multiple sclerosis (MS) has a strong racial and ethnic component and disproportionately affects
whites of European background. Recent incidence reports suggest an increasing rate of …

The blood-brain barrier (BBB) limits entry of blood-derived products, pathogens, and cells into
the brain that is essential for normal neuronal functioning and information processing. Post…

Background Craniopharyngiomas (CP) are locally invasive and frequently recurring neoplasms
often resulting in neurological and endocrinological dysfunction in children. In addition, …

Objective The radiologically isolated syndrome (RIS) represents the earliest detectable pre‐clinical
phase of multiple sclerosis (MS). This study evaluated the impact of therapeutic …

Background There is an unmet need to develop therapeutic interventions directed at the
neurodegeneration that underlies progression in multiple sclerosis. High-dose, pharmaceutical-…

… L. Amezcua serves on scientific advisory boards for Biogen Idec, Novartis, and Acorda; has
received funding for travel or speaker honoraria from Biogen, Novartis, Genzyme, and Acorda…

Background: Safety data on first-trimester natalizumab exposure are scarce, as natalizumab
is usually withdrawn three months before pregnancy. Objective: The objective of this paper …

Objective: To determine whether Epstein-Barr virus (EBV) or cytomegalovirus (CMV) seropositivity
is associated with multiple sclerosis (MS) in blacks and Hispanics and to what extent …

Accurate diagnosis of multiple sclerosis requires careful attention to its differential diagnosis—many
disorders can mimic the clinical manifestations and paraclinical findings of this …